友情链接:

  1. 澳门百家乐
  2. 真人百家乐
  3. 真人百家乐网
  4. 百家乐官网
网上百家乐 网页百家乐 澳门百家乐
Advantage

Out of constant pursuit of innovative corporate culture, CSC has very profound understanding to the society, economy, industry and the market, which endows us many unique advantages over other agencies.

●   Ability of leading and controlling the market

     To achieve the goal of leading and controlling the market, CSC would ensure each product it represents achieve No.1 position of market share, which is    

     far ahead of the second player, or else, CSC would give up the product. 

     This is the critical element which keeps the competitiveness and fighting spirit in CSC’s sales team and its good reputation in the industry.

 

 ●  Ability of choosing right products

     With proper consideration of patent, pharmacology, production process and sufficient market data, CSC well knows how to amplify its product line by       

     scientific analysis model and democratic decision-making mechanism.

     In view of classification of pharmacology, CSC optimizes its product list with series.

     For example: Domperidone, Domperidone Maleate, Mosapride Citrate, Itopride Hydrochloride, Cisapride, which are all under the category of gastric         

     dynamics drugs.

●  Rich experience as exclusive agency in China market

    For each product we represent, CSC shall make particular strategy, 3 to 5 years’ business plan, 3 to 5 years’ sales target, particular sales tactics and     

    implementation plan, and shall make a review and adjustment on a timely basis.

●  Excellent ability of marketing and sales

    Benefit from CSC's strong marketing capabilities, we are able to approach customers for a particular API quickly and accurately.

    CSC has set up very large customer’s network. Till Dec. 2018, CSC has set up business relationship with over 700 Chinese FDF customers. Among top    

   100 Chinese pharmaceutical companies, now over 90 ones have become CSC’s customers.

    From 2011 to 2018, CSC’s sales volume has increased nearly 10 times.

    In 2018, CSC’s annual sales volume reached 37 million US dollars.

 

Copyright © 2013 China Chinopharma Ltd. All rights reserved.

真人百家乐网 百家乐官网注册 真人百家乐官网 真人百家乐